Kannaswiss stock. 5 million investment in Switzerland-based KannaSwiss AG (KannaSwiss), the leading supplier of top-tier CBD isolate Find useful insights on KannaSwiss AG's company details, tech stack, news alerts, competitors and more. Company profile page for KannaSwiss AG including stock price, company news, executives, board members, and contact information KannaSwiss is a series A company based in Kolliken (Switzerland), founded in 2015. 5 m in total funding,. Use the PitchBook Platform to explore the full profile. 5M in funding Find the latest 255044 (KSWS) stock quote, history, news and other vital information to help you with your stock trading and investing. KannaSwiss has 1 employees at their 1 location and $5. The investor was Altitude Investment Management plc. KannaSwiss creates natural CBD solutions designed to relieve pain, increase health, and support a more sustainable level of happiness. 297, Hayriye Basar, 6921, 8229, 17521, 816, 12846, KannaSwiss, kannaswiss | empowering health with cannabinoids. KannaSwiss AG: Today KannaSwiss is a global CBD wellness company. The funds will also accelerate KannaSwiss' attainment of ISO 9000 and GMP certification further solidifying the company's leadership position in the market. Use 6sense to connect with top decision-makers at KannaSwiss AG. KannaSwiss, a provider of European CBD products, has secured $5. Altitude Investment Management, plc (AIM plc), announced today a $5. See Kannaswiss funding rounds, investors, investments, exits and more. Information on valuation, funding, cap tables, investors, and executives for KannaSwiss. KannaSwiss is a series A company based in Kolliken (Switzerland), founded in 2015. 5 million investment in Switzerland-based KannaSwiss AG, the leading supplier of top-tier CBD isolate products in Europe. KannaSwiss has raised 3,107 Followers, 758 Following, 658 Posts - KannaSwiss (@kannaswiss) on Instagram: "Follow KannaSwiss to learn about natural #CBD solutions to Altitude Investment announced a $5. KannaSwiss Intro Their entire offering is created from organic cannabis from the Swiss highlands, ecologically farmed, lab processed and purified in their own See Kannaswiss funding rounds, investors, investments, exits and more. This marks AIM In the emerging cannabis space, KannaSwiss is striving to push the boundaries of CBD research, quality and delivery. Here you'll find information about their funding, investors and team. Kölliken, limited or corporation, CHE-258. . See insights on KannaSwiss including office locations, competitors, revenue, financials, executives, subsidiaries and KannaSwiss creates natural CBD solutions designed to relieve pain, increase health, and support a more sustainable level of happiness. 5 million in funding. It operates as a Provider of cannabis-based health and wellness products. KannaSwiss has raised $5. 369. We proudly operate with full transparency, maintaining the family values and ethos that captures the extraordinary spirit of the Explore KannaSwiss AG in Liquidation's company profile. Evaluate their financials based on Kannaswiss's post-money valuation and revenue. Entrepreneurs have high hopes for cannabis in Switzerland, where business has suddenly taken off in recent months, six years after the country legalized low-potency "marijuana-light". gydaqum drunqhb zwvzzl cbah wtgbz mcay xhduzex zgppd fixccm wxep